GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » Shiller PE Ratio

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Shiller PE Ratio : 12.29 (As of May. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Shiller PE Ratio?

As of today (2024-05-26), Shanghai Pharmaceuticals Holding Co's current share price is HK$11.80. Shanghai Pharmaceuticals Holding Co's E10 for the quarter that ended in Mar. 2024 was HK$0.96. Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio for today is 12.29.

The historical rank and industry rank for Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio or its related term are showing as below:

HKSE:02607' s Shiller PE Ratio Range Over the Past 10 Years
Min: 11.21   Med: 19.42   Max: 52.63
Current: 12.66

During the past years, Shanghai Pharmaceuticals Holding Co's highest Shiller PE Ratio was 52.63. The lowest was 11.21. And the median was 19.42.

HKSE:02607's Shiller PE Ratio is ranked better than
81.13% of 53 companies
in the Medical Distribution industry
Industry Median: 18.11 vs HKSE:02607: 12.66

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's adjusted earnings per share data for the three months ended in Mar. 2024 was HK$0.456. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$0.96 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Pharmaceuticals Holding Co Shiller PE Ratio Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Shiller PE Ratio Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.71 15.49 14.93 12.53 11.77

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.18 15.63 12.43 11.77 11.73

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio falls into.



Shanghai Pharmaceuticals Holding Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=11.80/0.96
=12.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Shanghai Pharmaceuticals Holding Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.456/115.2271*115.2271
=0.456

Current CPI (Mar. 2024) = 115.2271.

Shanghai Pharmaceuticals Holding Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.339 98.200 0.398
201409 0.279 98.900 0.325
201412 0.316 99.000 0.368
201503 0.339 99.900 0.391
201506 0.372 99.500 0.431
201509 0.292 100.500 0.335
201512 0.312 100.600 0.357
201603 0.395 102.200 0.445
201606 0.369 101.400 0.419
201609 0.313 102.400 0.352
201612 0.308 102.600 0.346
201703 0.419 103.200 0.468
201706 0.394 103.100 0.440
201709 0.338 104.100 0.374
201712 0.367 104.500 0.405
201803 0.454 105.300 0.497
201806 0.433 104.900 0.476
201809 0.542 106.600 0.586
201812 0.200 106.500 0.216
201903 0.468 107.700 0.501
201906 0.454 107.700 0.486
201909 0.430 109.800 0.451
201912 0.267 111.200 0.277
202003 0.409 112.300 0.420
202006 0.536 110.400 0.559
202009 0.467 111.700 0.482
202012 0.367 111.500 0.379
202103 0.894 112.662 0.914
202106 0.616 111.769 0.635
202109 0.386 112.215 0.396
202112 0.257 113.108 0.262
202203 0.543 114.335 0.547
202206 0.809 114.558 0.814
202209 0.358 115.339 0.358
202212 0.179 115.116 0.179
202303 0.467 115.116 0.467
202306 0.328 114.558 0.330
202309 0.343 115.339 0.343
202312 -0.011 114.781 -0.011
202403 0.456 115.227 0.456

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Pharmaceuticals Holding Co  (HKSE:02607) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Shanghai Pharmaceuticals Holding Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (HKSE:02607) Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.
Executives
Blackrock, Inc. 2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited 2201 Interest of corporation controlled by you
Siic International Investment Company Limited 2101 Beneficial owner
Citigroup Inc. 2201 Interest of corporation controlled by you
Lsv Asset Management 2102 Investment manager

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Headlines

No Headlines